Monday, February 24, 2014

17-ALPHA HYDROXYPROGESTERONE, SERUM

Modification Reference values

Test code: 363
PREVIOUS
Reference values
CURRENT 
Reference values
Childs  (blood cord) :      9.0 -50.0  ng/mL
          (Prematures) :      0.26- 5.68 ng/mL
          (1 - 5 days) :      0.82- 4.20 ng/mL
          (5 - 30 days):      0.1 -16.8  ng/mL
          (30- 60 days):      1.9 - 9.8  ng/mL
          (60- 90 days):      0.1 - 4.0  ng/mL
     (Prepuberty phase):      0.10- 0.90 ng/mL
     (Puberal phase)   :      0.30- 1.55 ng/mL

Male                                 :  0.4 - 1.4 ng/mL

Female :  Follicular phase   : 0.1 - 1.2 ng/mL
                Luteinic phase     : 0.3 - 4.8 ng/mL
       Pregnant 1er Trimonthter: 0.6 -14.4 ng/mL
                2nd Trimonthter    : 2.1 -15.8 ng/mL
                3rd Trimonthter    : 3.8 -26.8 ng/mL
         Oral anticonceptives  : 0.1 - 1.2 ng/mL
         Menopause               : 0.1 - 0.6 ng/mL



Childs  (blood cord) :      9.0 -50.0  ng/mL
          (Prematures) :      0.26- 5.68 ng/mL
          (1 - 5 days) :      0.82- 4.20 ng/mL
          (5 - 30 days):      0.1 -16.8  ng/mL
          (30- 60 days):      1.9 - 9.8  ng/mL
          (60- 90 days):      0.1 - 4.0  ng/mL
     (Prepuberty phase):      0.10- 0.90 ng/mL
     (Puberal phase)   :      0.30- 1.55 ng/mL

Male                                 :  0.59 - 3.44 ng/mL

Female :  Follicular phase   : 0.11 - 1.08 ng/mL
          Luteinic phase            : 0.95 - 5.0  ng/mL
       Pregnant 1er Trimonthter: 2.50 - 9.78  ng/mL
                2nd Trimonthter    : 3.40 - 8.50  ng/mL
                3rd Trimonthte     : 4.53 - 18.86 ng/mL
         




    Find the record of the test by clicking here

Thursday, February 20, 2014

ETHOSUXIMIDE (ZARONTIN), SERUM

Modification Reference values

Test code: 347
PREVIOUS
Reference values
CURRENT 
Reference values


Therapeutic level (childs):     40 -  80 µg/mL
                               (Adults): 40 - 100 µg/mL
Toxic level                        :   >  150 µg/mL



Therapeutic level (childs): 40 -  80 µg/mL
                          (Adults): 40 - 100 µg/mL
Toxic level                     :   >  100 µg/mL
      



    Find the record of the test by clicking here

Wednesday, February 19, 2014

VITAMIN A (RETINOL), SERUM

Modification Reference values

Test code: 417
PREVIOUS
Reference values
CURRENT 
Reference values


From 0.2 to 0.5 mg/L


            0.4 - 1.1 mg/L



    Find the record of the test by clicking here

Monday, February 17, 2014

TOPIRAMATE, SERUM

Modification Method 

Test code: 3015
PREVIOUS 
 Method
CURRENT 
Method  

Fluorescente polaritation Immunoassay

Turbidimetric Immunoassay Particle



    Find the record of the test by clicking here

Friday, February 14, 2014

ANTI - ALVEOLLAR-LUNGS BASEMENT MEMBRANE, SERUM

Erased test in CIC Catalog
Test Code: 2242
Discontinued for technical reason (due to the absence of reagent in the market) and decrease in demand.

ACID PHOSPHATASE- TOTAL, SERUM

Modification Reference values

Test code: 436
PREVIOUS
Reference values
CURRENT 
Reference values

Less than 10 U/L (37ºC)



Less than 6.5 U/L
            



    Find the record of the test by clicking here

Thursday, February 13, 2014

IRREGULAR (IDENTIFICATION AND TITRATION) ANTIBODIES, WHOLE BLOOD

Modification Sample 

Test code: 2461

PREVIOUS
Sample 
CURRENT 
Sample 


Serum



EDTA  Whole blood 


    Find the record of the test by clicking here

INDIRECT COOMB'S (IDENTIFICATION AND TITRATION), WHOLE BLOOD

Modification Sample 

Test code: 2230

PREVIOUS
Sample 
CURRENT 
Sample 


Serum



EDTA  Whole blood 


    Find the record of the test by clicking here

GUANIDINACETATE, URINE

Modification Reference values

Test code: 3288
PREVIOUS
Reference values
CURRENT 
Reference values
Guandinoacetate       :  9.0  - 139.0 mmol/mol creatinine
creatine / creatinine :  0.01 -  1.63 mmol/mol creatinine

               Guandinoacetate       creatine/creatinine 
1d - 6y :         13 - 124              0.03 - 1.8
7y - 12y:          8 - 94               0.03 - 1.44
>12y    :         11 - 84               0.02 - 0.4

Units: mmol/mol creatinine




    Find the record of the test by clicking here

Tuesday, February 11, 2014

EVEROLIMUS, TOTAL BLOOD

Modification Method 

Test code: 1503
PREVIOUS 
 Method
CURRENT 
Method  

High Performance Liquid Chromatography

Particle homogeneous immunoassay



    Find the record of the test by clicking here

Friday, February 7, 2014

Kabuki, syndrome (exons 31,34,39,48 - MLL2) screening, whole blood

New Test in CIC Catalog

Test Code: 4468

Sample:
Whole blood - EDTA (5 ml)
Conservation:
Refrigerated
Method:
Sequencing Method
Set Up Days:
Daily
Delivery term:
50 days
Information:
FOR CATALOG INFORMATION SEE CODE 4467
Links:

    Find the record of the test by clicking here

Kabuki, syndrome (MLL2) sequencing, whole blood

New Test in CIC Catalog

Test Code: 4467

Sample:
Whole blood - EDTA (5 ml)
Conservation:
Refrigerated
Method:
Sequencing Method
Set Up Days:
Daily
Delivery term:
50 days
Information:
Kabuki syndrome (KS) is a multiple congenital anomaly syndrome characterized by typical facial features, skeletal anomalies, mild to moderate intellectual disability and postnatal growth deficiency. KS is associated, in 45 to 80% of cases, with mutations in the MLL2 gene. KDM6Agene deletions have also been reported in a few cases. Clinical diagnostic criteria for KS have not been established. Diagnosis relies on the clinical observation of 5 cardinal findings which are 1) cranio-facial features, 2) postnatal growth retardation, 3) skeletal anomalies, 4) persistence of fetal fingertips and 5) intellectual deficiency. Molecular analysis may confirm the clinical diagnosis. KS occurs sporadically in most cases but may have an autosomal dominant mode of inheritance with a subsequent 50% recurrence risk.
Links:

    Find the record of the test by clicking here

Thursday, February 6, 2014

LOW DENSITY LIPOPROTEIN (LDL OXIDATION ) ANTIBODIES, SERUM

Modification Reference values

Test code: 1168
PREVIOUS
Reference values
CURRENT 
Reference values

< 0.200 D.O.

Negative:    Less than 20 EU/mL
Indeterminate:    20 - 25 EU/mL
Positive: Greater than 25 EU/mL




    Find the record of the test by clicking here

Wednesday, February 5, 2014

DIAMINOXIDASE ( DAO ), PLASMA

Modification Delivery Time 

Test code: 1571
PREVIOUS
Delivery Time 
CURRENT 
Delivery Time 
 
Delivery time:  20 days

 
Delivery time: 7 days



    Find the record of the test by clicking here